Canada markets open in 2 hours 13 minutes

Sartorius Stedim Biotech S.A. (56S1.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
205.50-1.90 (-0.92%)
As of 08:03AM CEST. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 20.02B
Enterprise Value 23.58B
Trailing P/E 61.73
Forward P/E 34.97
PEG Ratio (5 yr expected) 1.38
Price/Sales (ttm)6.89
Price/Book (mrq)7.65
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.64
52-Week Change 3-15.76%
S&P500 52-Week Change 326.27%
52 Week High 3288.00
52 Week Low 3161.70
50-Day Moving Average 3244.53
200-Day Moving Average 3232.24

Share Statistics

Avg Vol (3 month) 3159
Avg Vol (10 day) 37
Shares Outstanding 597.3M
Implied Shares Outstanding 697.44M
Float 829.29M
% Held by Insiders 169.71%
% Held by Institutions 113.45%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.69
Forward Annual Dividend Yield 40.33%
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 40.51
Payout Ratio 442.86%
Dividend Date 3N/A
Ex-Dividend Date 4Apr 02, 2024
Last Split Factor 26:1
Last Split Date 3May 06, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 9.38%
Operating Margin (ttm)16.49%

Management Effectiveness

Return on Assets (ttm)3.92%
Return on Equity (ttm)8.15%

Income Statement

Revenue (ttm)2.72B
Revenue Per Share (ttm)29.09
Quarterly Revenue Growth (yoy)-8.20%
Gross Profit (ttm)N/A
EBITDA 635.8M
Net Income Avi to Common (ttm)254.7M
Diluted EPS (ttm)3.36
Quarterly Earnings Growth (yoy)-49.50%

Balance Sheet

Total Cash (mrq)695.1M
Total Cash Per Share (mrq)7.19
Total Debt (mrq)3.19B
Total Debt/Equity (mrq)82.46%
Current Ratio (mrq)2.13
Book Value Per Share (mrq)39.62

Cash Flow Statement

Operating Cash Flow (ttm)636.2M
Levered Free Cash Flow (ttm)27.25M